HomeDRMAW • NASDAQ
add
Dermata Therapeutics Inc
Previous close
$0.017
Year range
$0.010 - $0.030
Market cap
4.87M USD
Avg Volume
11.19K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.90M | -40.62% |
Net income | -1.86M | 40.91% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.52M | 137.92% |
Total assets | 7.86M | 122.53% |
Total liabilities | 1.64M | -16.85% |
Total equity | 6.22M | — |
Shares outstanding | 4.02M | — |
Price to book | 0.01 | — |
Return on assets | -73.46% | — |
Return on capital | -93.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.86M | 40.91% |
Cash from operations | -1.33M | 54.38% |
Cash from investing | — | — |
Cash from financing | 4.19M | 6,206.42% |
Net change in cash | 2.86M | 195.83% |
Free cash flow | -563.70K | 68.20% |
About
Founded
2014
Website
Employees
9
